C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings

Patents for C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978)
11/2002
11/19/2002	US6482952 One-step reaction of a carboxylic acid halide, a 1,2-aminoalcohol, and 2-alkoxypropene or 2,2-dialkoxypropane in an ether solvent and in the presence of lioh
11/19/2002	US6482951 Isoindolin-1-one glucokinase activators
11/19/2002	US6482947 Substituted (hetero) aryl compounds, process for their preparation, agents containing them and their use as safeners
11/14/2002	US20020169314 Sulfonamide derivative as a matrix metalloproteinase inhibitor
11/14/2002	US20020169312 Reacting N-aryl-O-alkylcarbamate with an amide derivative in the presence of a lithium cation, a base, and a nucleophile
11/14/2002	US20020169191 Oxazolidinone compounds and methods of preparation and use thereof
11/13/2002	EP1255754A1 Linezolid-crystal form ii
11/13/2002	EP1255736A2 Substituted piperazine derivatives and their use as inhibitors of the microsomal triglyceride transfer protein (mtp)
11/13/2002	EP0891340B1 Oxazole derivatives, their production and use
11/13/2002	EP0843672B1 One pot synthesis of 2-oxazolidinone derivatives
11/13/2002	CN1379762A Beta substituted metalloprotease inhibitors
11/12/2002	US6479694 Preparation of chiral cis-5-amino-2-cyclopenten-1-ol derivatives
11/12/2002	US6479665 Process for the preparation of N-carboxyanhydrides
11/12/2002	US6479552 Use of substituted N, N-disubstituted diamino compounds for inhibiting cholesteryl ester transfer protein activity
11/12/2002	US6479531 Gastrin and cholecystokinin receptor ligands
11/12/2002	CA2324959C Phthalimido compounds as intermediates for producing substance p receptor antagonists
11/07/2002	WO2002088274A1 Double-spiro organic compounds and electroluminescent devices
11/07/2002	WO2002087619A1 Preventive/therapeutic method for cancer
11/07/2002	WO2002087580A1 Abc expression promoters
11/07/2002	WO2002064546A3 Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical
11/07/2002	WO2002056827A3 Substituted felbamate derived compounds
11/07/2002	US20020165412 N-(aryl)-2-arylethenesulfonamides and therapeutic uses thereof
11/07/2002	US20020165393 Kinetic resolutions of chiral 2- and 3-substituted carboxylic acids
11/07/2002	US20020165232 Substituted N, N-disubstituted cycloalkyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
11/07/2002	US20020165231 Substituted N-heteroaryl-N-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
11/07/2002	US20020165219 Novel heterocycles useful in the treatment of benign prostatic hyperplasia
11/07/2002	US20020165095 Herbicidally active benzoylcyclohexanediones
11/06/2002	EP1254906A1 Tetrahydrothiopyran phenyloxazolidinone S,S-dioxides
11/06/2002	EP1254895A1 Nitrogenous cyclic compounds and pharmaceutical compositions containing the same
11/06/2002	EP1254667A1 Drug comprising combination
11/06/2002	EP1254136A1 FACTOR Xa INHIBITORS WITH ARYL-AMIDINES AND DERIVATIVES, AND PRODRUGS THEREOF
11/06/2002	EP1254115A2 Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators for treating respiratory and non-respiratory diseases
11/06/2002	CN1378540A New piperazine and piperidine compounds
11/06/2002	CN1378539A Thiocarbamic acid derivatives
11/05/2002	US6476232 4-(2-amino-1-hydroxyethyl)oxazoline derivative and method for producing same
11/05/2002	US6476231 Cyclization using acyl halogenide; chemical intermediate
11/05/2002	US6476075 Use of substituted N, N-bis-benzyl aminoalcohol compounds inhibiting cholesteryl ester transfer protein activity
11/05/2002	US6476057 Use of substituted N, N-disubstituted cycloalkyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity
11/05/2002	CA2038029C 1-alkyl-, 1-alkenyl- and 1-alkynylaryl-2-amino-1,3-propanediols and related compounds, a process and intermediates for their preparation and theeir use as medicaments
10/2002
10/31/2002	WO2002085865A1 A method for the preparation of oxazolidinones
10/31/2002	WO2002085849A2 Process to prepare oxazolidinones
10/31/2002	WO2002085838A1 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
10/31/2002	WO2002085836A1 Binaphtol derivative and process for producing the same
10/31/2002	WO2002085412A1 Tissue fibrosis inhibitors
10/31/2002	WO2002085357A1 Nociceptin analogs
10/31/2002	US20020161238 Novel methods for the preparation of taxanes using oxazolidine intermediates
10/31/2002	US20020161236 2-methyl-3-(protected hydroxy) benzyl chloride; use making nelfinavir mesylate
10/31/2002	US20020161028 Made by reacting a benzoxazole with a leaving group at the 2 position and a diamine of given formula
10/31/2002	US20020161019 For treatment of depression, anxiety, feeding disorders, headache, drug addiction, inflammatory disorders
10/31/2002	CA2444563A1 Tissue fibrosis inhibitors
10/31/2002	CA2440600A1 Process to prepare oxazolidinones
10/31/2002	CA2439959A1 A method for the preparation of oxazolidinones
10/30/2002	EP1252150A1 Novel heterocyclic derivatives, preparation method and pharmaceutical compositions containing same
10/30/2002	CN1377336A Carboxylic acid derivatives and drugs containing the same
10/30/2002	CN1377268A Cell adhesion inhibitors
10/30/2002	CN1376661A Indandione compounds and its preparing process and application
10/29/2002	US6472534 Treating tetrahydrofuran derivativ with an oxophilic electrophilic reagent in a manner that is effective to provide the oxazoline compound
10/29/2002	US6472529 Viricides
10/29/2002	US6472478 Gel or surface postcrosslinking of water-absorbing polymers in which the polymers are treated with a surface postcrosslinking solution and during or after the treatment are postcrosslinked and dried by means of an increase in
10/29/2002	US6472387 Methods of using compounds as neuro-protective agents
10/29/2002	US6472386 Cyclic diamine compound with 5-membered ring groups
10/24/2002	WO2002083656A2 5-membered heterocycles, preparation and use thereof as mao inhibitors and lipid peroxidation inhibitors, preparation thereof and use thereof as medicaments
10/24/2002	WO2002083649A1 Novel imidazolidinedione derivatives and use thereof as drugs
10/24/2002	WO2002083628A1 1,4-disubstituted benzo-fused compounds
10/24/2002	WO2002083111A2 Imidazole, thiazole and oxazole derivatives and their use for the manufacture of a medicament for the treatment and/or prevention of pollakiuria or urinary incontinence
10/24/2002	WO2002066449A3 Process for the preparation of mesylates of piperazine derivatives
10/24/2002	US20020156111 Substituted bicyclic compounds
10/24/2002	US20020156076 Imidazole derivatives used to reduce ocular pressure or treat glaucoma and other diseases
10/24/2002	US20020156072 Thiazine oxazolidinone
10/24/2002	US20020156070 Felbamate derived compounds
10/24/2002	US20020156063 Heterocyclic amide compounds useful for treating diseases associated with activity of cathepsin K
10/24/2002	US20020155985 Fragrance pro-accords and aldehyde and ketone fragrance libraries
10/24/2002	US20020155588 Very large scale immobilized polymer synthesis
10/24/2002	CA2444596A1 Large conductance calcium-activated k channel opener
10/24/2002	CA2443697A1 1,4-disubstituted benzo-fused compounds
10/23/2002	EP1251128A1 Cyclohexylamine derivatives as subtype selective N-methyl-D-aspartate antagonists
10/23/2002	EP1251127A1 Novel sidechain-bearing taxanes and intermediates thereof
10/23/2002	EP1250299A2 Chiral ionic liquids
10/23/2002	EP0674630B1 7-HALO- AND 7$g(b),8$g(b)-METHANO-TAXOLS, ANTINEOPLASTIC USE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
10/23/2002	CN1093124C Substituted 4-hydroxy-phenylalcanoic acid derivatives with agonist activity to PPAR-gamma
10/22/2002	US6469210 Excellent fungicidal activity
10/22/2002	US6469177 Cyclic n-halamines that are biocidal when they come in contact with halogen-sensitive organisms; achieved by coating the n-halamine on a substrate
10/22/2002	US6469047 Tyrosine derivatives
10/22/2002	US6469004 Benzoheterocycles and their uses as MEK inhibitors
10/17/2002	WO2002081478A2 Broadspectrum 2-(substituted-amino)-benzoxazole sulfonamide hiv protease inhibitors
10/17/2002	WO2002081463A1 Antagonists of mcp-1 function and methods of use thereof
10/17/2002	WO2002081435A1 Sulphones which modulate the action of gamma secretase
10/17/2002	WO2002080920A1 Arylacetamido-ketobenzoxazole as cysteine protease inhibitors
10/17/2002	WO2002050081A3 Antimicrobial agents
10/17/2002	WO2002044156A3 Benzimidazole derivatives useful as tie-2 and/or vegfr-2 inhibitors
10/17/2002	US20020151744 Kinetic resolutions of chiral 2-and-3-substituted carboxylic acids
10/17/2002	US20020151722 Production method of beta-amino-alpha-hydroxycarboxylic acid
10/17/2002	US20020151720 Naphthol derivatives
10/17/2002	US20020151535 Heterocyclic 1,2,4-oxadiazole or oxazole ring containing propanohydroxamic acids useful as antiscarring agent
10/17/2002	US20020151531 Administering to a female of child bearing age over a period of 28 consecutive days a first phase of from 18 to 21 daily dosage units of a progestational agent, and a second phase of from 1 to 7 daily dosage units of an antiprogestin agent
10/17/2002	CA2442776A1 Antagonists of mcp-1 function and methods of use thereof
10/16/2002	EP1248761A1 Compounds which mimic the chemical and biological properties of discodermolide
10/16/2002	EP1248615A1 Thiazole, imidazole and oxazole compounds and treatments of disorders associated with protein aging
10/16/2002	EP1248612A1 Novel compounds and compositions as protease inhibitors
10/16/2002	EP0813542B1 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors

1 ... 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 ... 210